No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Why Astrazeneca (AZN) Is a Top Value Stock for the Long-Term
AZN, Daiichi's ADC Gets FDA Breakthrough Tag for EGFR-Mutated NSCLC
AstraZeneca (AZN) Receives a Hold From Jefferies
Astrazeneca (AZN.US) has achieved breakthrough therapy designation for a potential blockbuster ADC.
Astrazeneca (AZN.US) has a potential blockbuster ADC that has been granted breakthrough therapy designation.
AstraZeneca Gets FDA Breakthrough Therapy Status for Dato-DXd
Merck Reports Mixed Results From Keytruda Ovarian Cancer Study